Recent performance snapshot
Axon Enterprise (AXON) has pulled back recently, with the share price down around 1.5% over the past day, 16% over the past week, and roughly one third over the past month.
Over the past 3 months, the stock has declined about 45%. The year-to-date move is roughly 39% lower, leaving the 1-year total return also about 39% in the red.
See our latest analysis for Axon Enterprise.
The recent drop in Axon Enterprise's share price, with the current level around $345.94, sits alongside a three year total shareholder return of 54.50% and 126.49% over five years. This suggests long term holders still retain significant gains even as short term momentum has faded.
If Axon's pullback has you thinking about where growth and risk might look different across the market, it could be a good time to scan for 36 AI infrastructure stocks
With Axon Enterprise now down sharply from recent levels, yet still carrying a value score of 4 and trading at an intrinsic discount of about 10%, should you see a mispriced opportunity here or assume the market is already factoring in future growth?
Most Popular Narrative: 43% Undervalued
Axon Enterprise's narrative fair value of $606.83 sits well above the last close at $345.94, which puts a spotlight on the reasoning behind that gap.
One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.
Curious what justifies such a big gap between price and fair value? The narrative leans on fast compounding growth, expanding margins, and a premium earnings multiple that assumes Axon earns a software like profile over time.
Result: Fair Value of $606.83 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you also need to weigh risks such as slower adoption of Axon’s software platform or tighter public safety budgets that constrain spending on new technology contracts.
Find out about the key risks to this Axon Enterprise narrative.
Next Steps
Given the mix of optimism and concern running through this story, it makes sense to look at the numbers yourself and move quickly to shape your own view by weighing 3 key rewards and 3 important warning signs
Looking for more investment ideas?
If Axon has sharpened your focus, do not stop here. Broaden your watchlist with a few hand picked sets of companies that meet clear, simple criteria.
- Target long term compounding potential by scanning for companies that combine quality and attractive pricing through the 62 high quality undervalued stocks
- Prioritize resilience by reviewing companies with strong finances and clear fundamentals using the solid balance sheet and fundamentals stocks screener (40 results)
- Spot earlier stage opportunities before they hit the mainstream by checking the 32 elite penny stocks with strong financials
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com